LIDE Biotech
LIDE is a preclinical oncology CRO offering classical drug efficacy mouse models like CDX and more than 2200 patient derived xenograft (PDX), covering 40+ cancer types. LIDE is unique with its 200+ naturally drug resistant models, and more importantly, its proprietary MiniPDX and IO FIVE 7-day in-vivo assays. We also offer in-vitro 2D and 3D (spheroid, organoid) assays.
Founded in 2011 by overseas returnees, LIDE brings together first-class research and management teams with advanced scientific backgrounds to push the frontier of translational medical research. We operate at the forefront of new technologies and adopt the highest international accreditation standards. The company owns AAALAC accredited SPF level Animal Centers, safety level 2 laboratories and world-class, state of the art equipment.
